Pediatric Drugs Market
Global Pediatric Drugs Market Size, Share & Trends Analysis Report, by Drug Type (Allergy and Respiratory Drugs, Cancer Therapies, Cardiovascular Drugs, Gastrointestinal Drugs, and Others), by Route of Administration (Oral, Topical, Parenteral, and Other), by Application (Pediatric Clinical Pharmacology, Pediatric Pharmacotherapy, and Pediatric Pharmacy) Forecast Period (2020-2026)
The pediatric drugs market is projected to grow at a considerable CAGR of around 5% during the, forecast period (2020-2026). The growing prevalence of several disorders such as asthma, anorexia, birth defects, cancer in children, growth deficiencies, juvenile diabetes, and attention deficit hyperactivity among others is a major factor creating the demand for pediatric drugs. The presence of several acts such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) is further propelling the major players to increase the investments on R&D activities for the development of the pediatric drugs. Furthermore, the growing pediatric population across the globe is predicted to accelerate the demand for pediatric drugs which in turn, is anticipated to drive the market growth. According to the US-based non-profit organization Child Trends, in 2017, there were 73.7 million children younger than 18 in the US, accounting for 22.6% of the total population.
In addition, growing R&D activities in pediatric drugs, improvements in the immunization program and the proliferation of pediatric drugs in the emerging countries are among the major factors that are promoting the growth of the pediatric drugs market during the forecast period. However, the lack of accessibility of pediatric drugs in emerging countries due to lack of awareness and healthcare infrastructure are the major factors that are anticipated to restrict the growth of the global pediatric drugs market. In addition, side effects associated with the dosage of pediatric drugs such as anxiety, headache, and fatigue are the other factors to restrain its market growth.
Segmental Outlook
The Pediatric drugs market is segmented on the basis of drug type, route of administration, and application. Based on drug type, the market is segmented into allergy and respiratory drugs, cancer therapies, cardiovascular drugs, gastrointestinal drugs, and others. Based on the route of administration, the market is segmented into oral, topical, parenteral, and other. Based on the application, the market is segmented into pediatric clinical pharmacology, pediatric pharmacotherapy, and pediatric pharmacy.
Oral will be considerable segment by route of administration
Oral is anticipated to hold considerable market share during the forecast period. Convenience, safety, and cost-efficiency are the key factors to promote the growth of this market segment. However, their characteristic of moving through the digestive tract may hinder their adoption rate as they are not directly applied to the target site.
Global Pediatric Drugs Market Share by Route of Administration, 2018 (%)
Regional Outlook
The global pediatric drug market is further segmented on the basis of geography including North America, Europe, Asia-Pacific and Rest of the World. North America is anticipated to hold a considerable share in the global pediatric drugs market during the forecast period. The presence of large children pool in the region along with the growing availability of the option to treat pediatric diseases is driving the regional growth of the market. Well-established healthcare system and high per capita healthcare expenditure are some other motivators for the growth of the pediatric drugs market in North America. Moreover, easy access to advanced pediatric drugs owing to the improvements in the R&D activities along with the huge demand for such drugs in medical facilities to further expected to drive the market growth in North America.
Global Pediatric drugs Market Growth, by Region 2019-2025
Asia-Pacific will augment with the significant growth rate in the pediatric drugs market
The major economies contributing to the regional growth of the market include China, Japan, and India. The rising awareness related to pediatric diseases along with the growing access to advanced pediatric drugs is anticipated to drive the growth of the market in the region. The increasing disposable incomes and developing healthcare infrastructure in the emerging countries of the region are anticipated to drive the growth of the market.
Market Players Outlook
Some of the key players in the market include Novartis International AG, Allergan PLC, Johnson & Johnson Services Inc., F. Hoffman La Roche, Pfizer Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly and Co., and so on. These market players are actively adopting various organic and inorganic growth strategies such as mergers and acquisitions and product launch in order to expand their share in the market and gain a competitive advantage over other players. For instance, in March 2017 MedImmune LLC (AstraZeneca) had entered into an agreement with Sanofi Pasteur, the vaccine division of Sanofi for the development and commercialization of MEDI8897.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global pediatric drugs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Novartis International AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Bristol-Myers Squibb Co.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. F. Hoffman La Roche, Ltd.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Merck KGaA
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Allergan PLC
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Global Pediatric Drugs Market by Drug Type
5.1.1. Allergy and Respiratory Drugs
5.1.2. Cancer Therapies
5.1.3. Cardiovascular Drugs
5.1.4. Gastrointestinal Drugs
5.1.5. Others
5.2. Global Pediatric Drugs Market by Route of Administration
5.2.1. Oral
5.2.2. Topical
5.2.3. Parenteral
5.2.4. Other (Buccal)
5.3. Global Pediatric Drugs Market by Application
5.3.1. Pediatric Clinical Pharmacology
5.3.2. Pediatric Pharmacotherapy
5.3.3. Pediatric Pharmacy
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Allergan PLC
7.3. AstraZeneca PLC
7.4. AYTU BioScience, Inc.
7.5. Bayer AG
7.6. BioMarin Pharmaceutical, Inc.
7.7. Boehringer Ingelheim International GmbH
7.8. Bristol-Myers Squibb Co.
7.9. Eisai Inc
7.10. Eli Lilly Co.
7.11. F. Hoffman La Roche, Ltd.
7.12. Genentech, Inc.
7.13. GlaxoSmithKline PLC
7.14. Johnson & Johnson, Inc.
7.15. Mallinckrodt PLC
7.16. Merck KGaA
7.17. Novartis International AG
7.18. Novo Nordisk A/S
7.19. Pfizer, Inc.
7.20. Teva Pharmaceutical Industries, Ltd.
1. GLOBAL PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
2. GLOBAL ALLERGY AND RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL CANCER THERAPIES MARKET RESEARCH AND ANALYSIS BY REGION,2019-2026 ($ MILLION)
4. GLOBAL CARDIOVASCULAR DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL GASTROINTESTINAL DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
8. GLOBAL ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL TOPICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL PARENTERAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. GLOBAL PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
13. GLOBAL PEDIATRIC CLINICAL PHARMACOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
14. GLOBAL PEDIATRIC PHARMACOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. GLOBAL PEDIATRIC PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
16. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
17. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
18. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
19. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
20. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
21. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
22. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
23. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
24. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
25. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
26. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
27. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
28. REST OF THE WORLD PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
29. REST OF THE WORLD PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
30. REST OF THE WORLD PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
1. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY DRUG TYPE, 2019 VS 2026 (%)
2. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY ROUTE OF ADMINISTRATION, 2019 VS 2026 (%)
3. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
4. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
5. THE US PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
6. CANADA PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
7. UK PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
8. FRANCE PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
9. GERMANY PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
10. ITALY PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
11. SPAIN PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
12. ROE PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
13. INDIA PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
14. CHINA PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
15. JAPAN PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF ASIA-PACIFIC PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
17. REST OF THE WORLD PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
